BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30876923)

  • 1. Has adherence to treatment guidelines for mid/low rectal cancer affected the management of patients? A monocentric study of 604 consecutive patients.
    Eid Y; Menahem B; Bouvier V; Lebreton G; Thobie A; Bazille C; Finochi M; Fohlen A; Galais MP; Dupont B; Lubrano J; Dejardin O; Morello R; Alves A
    J Visc Surg; 2019 Sep; 156(4):281-290. PubMed ID: 30876923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of rectal cancers in relation to treatment guidelines: a population-based study comparing Italian and French patients.
    Minicozzi P; Bouvier AM; Faivre J; Sant M;
    Dig Liver Dis; 2014 Jul; 46(7):645-51. PubMed ID: 24746280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a Completion Total Mesorectal Excision in Patients After Local Excision of Rectal Cancer: A Word of Caution.
    van Groningen JT; van Hagen P; Tollenaar RAEM; Tuynman JB; de Mheen PJM; Doornebosch PG; Tanis PJ; de Graaf EJR;
    J Natl Compr Canc Netw; 2018 Jul; 16(7):822-828. PubMed ID: 30006424
    [No Abstract]   [Full Text] [Related]  

  • 4. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
    Law WL; Chu KW
    Ann Surg; 2004 Aug; 240(2):260-8. PubMed ID: 15273550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of rectal cancer: the 2016 French guidelines.
    Lakkis Z; Manceau G; Bridoux V; Brouquet A; Kirzin S; Maggiori L; de Chaisemartin C; Lefevre JH; Panis Y;
    Colorectal Dis; 2017 Feb; 19(2):115-122. PubMed ID: 27801543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related guideline adherence and outcome in low rectal cancer.
    Schiphorst AH; Verweij NM; Pronk A; Hamaker ME
    Dis Colon Rectum; 2014 Aug; 57(8):967-75. PubMed ID: 25003291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
    World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
    Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
    Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphincter-Sparing Surgery in Patients with Mid and Low Rectal Cancer - Risk Factors for Local Recurrence and Anastomotic Leakage.
    Aslan D; Grama F; Cristian D; Bordea A; Burcoş T;
    Chirurgia (Bucur); 2016; 111(6):481-486. PubMed ID: 28044949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of surgical margins in rectal cancer.
    Mukkai Krishnamurty D; Wise PE
    J Surg Oncol; 2016 Mar; 113(3):323-32. PubMed ID: 27094456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple instruments facilitating achievement of transanal total mesorectal excision in male patients.
    Xu C; Song HY; Han SL; Ni SC; Zhang HX; Xing CG
    World J Gastroenterol; 2017 Aug; 23(31):5798-5808. PubMed ID: 28883706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010.
    Ghouti L; Pereira P; Filleron T; Humeau M; Guimbaud R; Selves J; Carrere N
    Am J Surg; 2015 Feb; 209(2):352-62. PubMed ID: 25524284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service.
    Enker WE; Merchant N; Cohen AM; Lanouette NM; Swallow C; Guillem J; Paty P; Minsky B; Weyrauch K; Quan SH
    Ann Surg; 1999 Oct; 230(4):544-52; discussion 552-4. PubMed ID: 10522724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
    Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
    BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit.
    Wibe A; Møller B; Norstein J; Carlsen E; Wiig JN; Heald RJ; Langmark F; Myrvold HE; Søreide O;
    Dis Colon Rectum; 2002 Jul; 45(7):857-66. PubMed ID: 12130870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postoperative complications of curative treatment for rectal cancer in males with sphincter-preserving total mesorectal excision].
    Szynglarewicz B; Matkowski R; Sydor D; Forgacz J; Pudełko M; Grzebieniak Z
    Pol Merkur Lekarski; 2007 Nov; 23(137):348-51. PubMed ID: 18361317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local excision followed by early radical surgery in rectal cancer: long-term outcome.
    Junginger T; Goenner U; Hitzler M; Trinh TT; Heintz A; Wollschläger D
    World J Surg Oncol; 2019 Oct; 17(1):168. PubMed ID: 31594546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the short-term outcomes in lower rectal cancer using three different surgical techniques: Transanal total mesorectal excision (TME), laparoscopic TME, and open TME.
    Chen YT; Kiu KT; Yen MH; Chang TC
    Asian J Surg; 2019 Jun; 42(6):674-680. PubMed ID: 30318319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of adenocarcinoma of the rectum.
    Zaheer S; Pemberton JH; Farouk R; Dozois RR; Wolff BG; Ilstrup D
    Ann Surg; 1998 Jun; 227(6):800-11. PubMed ID: 9637543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
    Deijen CL; Velthuis S; Tsai A; Mavroveli S; de Lange-de Klerk ES; Sietses C; Tuynman JB; Lacy AM; Hanna GB; Bonjer HJ
    Surg Endosc; 2016 Aug; 30(8):3210-5. PubMed ID: 26537907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.